Results 41 to 50 of about 515 (75)
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City. [PDF]
NatureZiyatdinov A, Torres J, Alegre-Díaz J, Backman J, Mbatchou J, Turner M, Gaynor SM, Joseph T, Zou Y, Liu D, Wade R, Staples J, Panea R, Popov A, Bai X, Balasubramanian S, Habegger L, Lanche R, Lopez A, Maxwell E, Jones M, García-Ortiz H, Ramirez-Reyes R, Santacruz-Benítez R, Nag A, Smith KR, Damask A, Lin N, Paulding C, Reppell M, Zöllner S, Jorgenson E, Salerno W, Petrovski S, Overton J, Reid J, Thornton TA, Abecasis G, Berumen J, Orozco-Orozco L, Collins R, Regeneron Genetics Center, Mexico City Prospective Study, Baras A, Hill MR, Emberson JR, Marchini J, Kuri-Morales P, Tapia-Conyer R. +48 moreeuropepmc +1 more sourceEffectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe. [PDF]
Pediatr Infect Dis JMalik F, Crichton S, Crichton S, Plotnikova Y, Latysheva I, Samarina A, Pokorska-Śpiewak M, Gomez MN, Bailey H, Thorne C, Judd A, Turkova A, Collins IJ. +12 moreeuropepmc +1 more sourceEmerging Approaches to Anthelmintic Therapy Using Medicinal Plants and Phytochemicals: A Review of Natural Products Against Strongyloidiasis. [PDF]
PathogensLópez-Abán J, Vicente-Santiago B, Gutiérrez-Soto G, Rodríguez-Garza NE, Kačániová M, López-Sandin I, Romo-Sáenz CI, Ballesteros-Torres JM, Galaviz-Silva L, Castillo-Velázquez U, Garzoli S, Elizondo-Luévano JH. +11 moreeuropepmc +1 more sourceUrate Levels as a Predictor of the Prevalence and Level of Cardiovascular Risk Factors: An Identificación de La PoBlación Española de Riesgo Cardiovascular y Renal Study. [PDF]
BiomoleculesAntelo-Pais P, Prieto-Díaz MÁ, Micó-Pérez RM, Pallarés-Carratalá V, Velilla-Zancada S, Polo-García J, Barquilla-García A, Ginel-Mendoza L, Segura-Fragoso A, Vitelli-Storelli F, Martín-Sánchez V, Hermida-Ameijerias Á, Cinza-Sanjurjo S, On Behalf Of The Investigators Of The Iberican Study And Of The Spanish Society Of Primary Care Physicians Semergen Foundation. +13 moreeuropepmc +1 more sourceProtecting stable biological nomenclatural systems enables universal communication: A collective international appeal. [PDF]
BioscienceJiménez-Mejías P, Manzano S, Gowda V, Krell FT, Lin MY, Martín-Bravo S, Martín-Torrijos L, Nieto Feliner G, Mosyakin SL, Naczi RFC, Acedo C, Álvarez I, Crisci JV, Luceño Garcés M, Manning J, Moreno Saiz JC, Muasya AM, Riina R, Meseguer AS, Sánchez-Mata D, 1543 additional coauthors . +20 moreeuropepmc +1 more sourcePhase 2/3 study evaluating safety, immunogenicity, and noninferiority of single booster dose of AVX/COVID-12 vaccine. [PDF]
Sci AdvLópez-Macías C, Torres M, Armenta-Copca B, Wacher NH, Galindo-Fraga A, Castro-Castrezana L, Colli-Domínguez AA, Cervantes-Trujano E, Rucker-Joerg IE, Lozano-Patiño F, Rivera-Alcocer JJ, Simón-Campos A, Sánchez-Campos EA, Aguirre-Rivero R, Muñiz-Carvajal AJ, Del Carpio-Orantes L, Márquez-Díaz F, Rivera-Hernández T, Torres-Flores A, Ramírez-Martínez L, la Rosa GP, Rojas-Martínez O, Suárez-Martínez A, Peralta-Sánchez G, Carranza C, Juárez E, Zamudio-Meza H, Carreto-Binaghi LE, Viettri M, Romero-Rodríguez D, Palencia A, Sarfati-Mizrahi D, Sun W, Chagoya-Cortés HE, Castro-Peralta F, Palese P, Krammer F, García-Sastre A, Lozano-Dubernard B. +38 moreeuropepmc +1 more sourceHeterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C). [PDF]
J Exp MedBellos E, Santillo D, Vantourout P, Jackson HR, Duret A, Hearn H, Seeleuthner Y, Talouarn E, Hodeib S, Patel H, Powell O, Yeoh S, Mustafa S, Habgood-Coote D, Nichols S, Estramiana Elorrieta L, D'Souza G, Wright VJ, Estrada-Rivadeneyra D, Tremoulet AH, Dummer KB, Netea SA, Condino-Neto A, Lau YL, Núñez Cuadros E, Toubiana J, Holanda Pena M, Rieux-Laucat F, Luyt CE, Haerynck F, Mège JL, Chakravorty S, Haddad E, Morin MP, Metin Akcan Ö, Keles S, Emiroglu M, Alkan G, Tüter Öz SK, Elmas Bozdemir S, Morelle G, Volokha A, Kendir-Demirkol Y, Sözeri B, Coskuner T, Yahsi A, Gulhan B, Kanik-Yuksek S, Bayhan GI, Ozkaya-Parlakay A, Yesilbas O, Hatipoglu N, Ozcelik T, Belot A, Chopin E, Barlogis V, Sevketoglu E, Menentoglu E, Gayretli Aydin ZG, Bloomfield M, AlKhater SA, Cyrus C, Stepanovskiy Y, Bondarenko A, Öz FN, Polat M, Fremuth J, Lebl J, Geraldo A, Jouanguy E, COVID-19 Human Genetic Effort, DIAMONDS, EUCLIDS, Carter MJ, Wellman P, Peters M, Pérez de Diego R, Edwards LA, Chiu C, Noursadeghi M, Bolze A, Shimizu C, Kaforou M, Hamilton MS, Herberg JA, Schmitt EG, Rodriguez-Palmero A, Pujol A, Kim J, Cobat A, Abel L, Zhang SY, Casanova JL, Kuijpers TW, Burns JC, Levin M, Hayday AC, Sancho-Shimizu V. +97 moreeuropepmc +1 more sourceAdd-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial.
JAMADesai AS, Karns AD, Badariene J, Aswad A, Neutel JM, Kazi F, Park W, Stiglitz D, Makarova N, Havasi A, Zappe DH, Saxena M, KARDIA-2 Study Group. +12 moreeuropepmc +1 more source